Nov 12, 2018
Soligenix Selected to Present RiVax® Data at the Fourth International Conference on Vaccines Research & Development in Baltimore, Maryland
Oct 19, 2018
Celebrate the Acceleration of Technology Innovations in Our Region at the 10th Annual FITCI/Fort Detrick Alliance Technology Showcase
Oct 04, 2018
Russia accuses US of running bio arms lab in Georgia
Sep 18, 2018
Trump unveils revised US biodefense strategy
Sep 17, 2018
PathSensors Reaches Japan Through Partnership With Ensensor
Sep 05, 2018
Soligenix to Present at BioCentury's 25th Annual NewsMakers in the Biotech Industry
Sep 04, 2018
Soligenix Announces Publication of Positive Long-Term Data Supporting Thermostability and Conformational Integrity of the RiVax® Ricin Toxin Vaccine
Aug 08, 2018
Soligenix Announces Recent Accomplishments And Second Quarter 2018 Financial Results
Aug 07, 2018
Global Biodefense Market Analysis, Growth, Trends & Forecast 2018-2023, With an Expected CAGR of 6.5% - ResearchAndMarkets.com
Jul 26, 2018
Soligenix Announces a RiVax® Program Presentation at the 31st Annual Congress on Vaccines, Clinical Trials & B2B in Vancouver, Canada
Jul 09, 2018
Soligenix Receives European and Canadian Patents for its Ricin Toxin Vaccine (RiVax®) Formulation
Jun 04, 2018
ABL, Inc. Announces Hiring of Marykay Marchigiani as Chief Financial Officer
May 11, 2018
Soligenix Announces Recent Accomplishments And First Quarter 2018 Financial Results
Apr 23, 2018
Elusys Receives Second Delivery Order From U.S. Government for ANTHIM®, its Treatment for Inhalation Anthrax
Mar 22, 2018
Soligenix Receives Orphan Drug Designation from the European Commission for RiVax® for Prevention of Ricin Poisoning
Mar 15, 2018
Soligenix Announces Recent Accomplishments And Year-End 2017 Financial Results
Mar 13, 2018
Soligenix to Present at the 12th Annual International Partnering Conference Bio-Europe Spring
Jan 25, 2018
Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials
Dec 21, 2017
Soligenix Identifies Biomarkers for Ricin Toxin Vaccine Testing under the FDA Animal Rule
Dec 15, 2017
Global Biodefense Market Growth Fuelled by Growing Threat of Bioterrorism | Technavio